Shared Decision-Making in Advanced or Recurrent Endometrial Cancer

The panel discusses factors to consider when determining best treatment options for patients with recurrent or advanced endometrial cancer, including traditional clinical trial endpoints, cost, chance for cure versus disease control, and most importantly, patient preference.

Related Content:

Recent Advances in Treating Endometrial and Cervical CancersOncLive Peer Exchange® Gynecologic Oncology

Clinical Considerations for 2L Treatment Sequencing in mCRC

Overview of Molecular Testing and Barriers in mCRC

ADRIATIC Trial: Durvalumab, cCRT Timing, and Survival in LS-SCLC